The accumulation of blood products have certain characteristics in the healthcare market in China. First, they are one of the most advanced products on the Chinese healthcare market, were classified as products of the accumulation of blood in two regulatory categories: medicine and health foods.
Second, accumulation of blood product ingredients have been three main categories, namely, chemicals, food ingredients, generic and Chinese herbs such as angelica and donkey hide gelatin. Third, through marketing campaigns always have people now believed that there are three types of enrichment of blood products in terms of efficiency: the enrichment of pure blood, the blood and the enrichment and strengthening of dual-energy of the female body.
We can say that China is a comprehensive market intelligence the result of blood fortress of consumers in the last 10 years. Currently, the share of drugs in this market worth about 2 billion yuan (U.S. $ 260 million), while the part of health food is about RMB 2-2500000000 (U.S. $ 260-330000000).
Products
In relation to the accumulation of blood products, the category of health food stores, the best contributions to the industry so far. Gave a survey in the spring of 2006, about 600-700 characters of blood for food fortification in China, with key national stakeholders, such as Red Heart King Group, Joincare Pharmaceutical Group, Hong Fu International Law, Harbin Pharmaceutical sixth Pharm Factory Group, Hengan Group and the group Yangshengtang, and dozens of regional brand leaders.
The segment of the drug, blood enrichment was relatively less competitive segments of the blood with food enrichment. There were only a handful of serious national players, such as Dong-E E-Jiao Group, Jiuzhitang Group, Jilin and Shandong Xiuzheng Fujiao pharmaceutical company, and there was rarely a regional leader registered. Dong-E E-Jiao Group was the dominant player in this market with 43% share of the domestic market and 75% share in the export market for three consecutive years. » Read more: Analysis on China’s Blood Enrichment Products Market